Compare Stocks

Date Range: 

 Corcept TherapeuticsRocket PharmaceuticalsDeciphera PharmaceuticalsAmicus TherapeuticsOrganogenesis
SymbolNASDAQ:CORTNASDAQ:RCKTNASDAQ:DCPHNASDAQ:FOLDNASDAQ:ORGO
Price Information
Current Price$21.10$43.77$34.33$9.75$21.15
52 Week RangeBuyBuyBuyHoldBuy
MarketRank™
Overall Score1.81.41.81.61.0
Analysis Score2.33.54.44.21.5
Community Score2.72.92.53.02.6
Dividend Score0.00.00.00.00.0
Ownership Score1.70.81.70.00.8
Earnings & Valuation Score2.50.00.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldBuy
Consensus Price Target$24.00$59.18$73.00$20.04$16.50
% Upside from Price Target13.74% upside35.21% upside112.64% upside105.52% upside-21.99% downside
Trade Information
Market Cap$2.46 billion$2.70 billion$1.99 billion$2.59 billion$2.71 billion
Beta1.042.051.491.571.84
Average Volume554,552482,502453,8213,716,117824,795
Sales & Book Value
Annual Revenue$306.49 millionN/A$25 million$182.24 million$260.98 million
Price / Sales8.03N/A79.6014.2310.39
Cashflow$0.63 per shareN/AN/AN/AN/A
Price / Cash33.26N/AN/AN/AN/A
Book Value$3.25 per share$6.10 per share$10.71 per share$1.87 per share$0.59 per share
Price / Book6.49N/A3.215.2135.85
Profitability
Net Income$94.18 million$-77,270,000.00$-192,260,000.00$-356,390,000.00$-40,450,000.00
EPS$0.77($1.58)($4.48)($1.31)($0.42)
Trailing P/E Ratio23.71N/AN/AN/AN/A
Forward P/E Ratio22.93N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins30.73%N/AN/A-120.18%-1.61%
Return on Equity (ROE)25.38%-35.81%-45.02%-73.81%-10.03%
Return on Assets (ROA)23.16%-27.52%-40.12%-36.10%-2.22%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.25%N/A1.21%1.54%
Current Ratio10.77%7.30%9.34%5.24%1.95%
Quick Ratio10.65%7.30%9.26%5.10%1.50%
Ownership Information
Institutional Ownership Percentage75.44%N/A73.61%N/A4.62%
Insider Ownership Percentage16.40%41.40%7.02%2.50%57.20%
Miscellaneous
Employees23691350483910
Shares Outstanding116.63 million61.78 million57.96 million266.03 million128.21 million
Next Earnings Date8/3/2021 (Estimated)5/12/2021 (Estimated)8/3/2021 (Estimated)5/10/2021 (Confirmed)5/10/2021 (Confirmed)
OptionableOptionableOptionableOptionableOptionableNot Optionable
SourceHeadline
Organogenesis Showcases Latest Advanced Wound Care - GlobeNewswireOrganogenesis Showcases Latest Advanced Wound Care - GlobeNewswire
globenewswire.com - May 8 at 8:50 AM
Zacks Investment Research Lowers Organogenesis (NASDAQ:ORGO) to HoldZacks Investment Research Lowers Organogenesis (NASDAQ:ORGO) to Hold
marketbeat.com - May 8 at 2:26 AM
Earnings Outlook for Organogenesis Holdings - BenzingaEarnings Outlook for Organogenesis Holdings - Benzinga
benzinga.com - May 7 at 1:02 PM
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring | WHS 2021 Virtual Meeting - Yahoo FinanceOrganogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring | WHS 2021 Virtual Meeting - Yahoo Finance
finance.yahoo.com - May 6 at 10:01 PM
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring | WHS 2021 Virtual MeetingOrganogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring | WHS 2021 Virtual Meeting
finance.yahoo.com - May 6 at 10:01 PM
05:00 ET 2020 STELLARIS Award Recipient Announced - PRNewswire05:00 ET 2020 STELLARIS Award Recipient Announced - PRNewswire
prnewswire.com - May 6 at 7:00 AM
Automotive Axle and Propeller Shaft Market 2026 Maximum Benefit and Growth Potential During this COVID 19 Outbreak | 3M, Organogenesis, Smith & Nephew, ConvaTec Group, Coloplast – FLA News - FLA NewsAutomotive Axle and Propeller Shaft Market 2026 Maximum Benefit and Growth Potential During this COVID 19 Outbreak | 3M, Organogenesis, Smith & Nephew, ConvaTec Group, Coloplast – FLA News - FLA News
flanewsonline.com - May 5 at 3:54 PM
A Look At The Fair Value Of Organogenesis Holdings Inc. (NASDAQ:ORGO) - NasdaqA Look At The Fair Value Of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Nasdaq
nasdaq.com - May 5 at 3:54 PM
Has Organogenesis Holdings Inc.s (NASDAQ:ORGO) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - Yahoo FinanceHas Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - Yahoo Finance
finance.yahoo.com - May 5 at 3:54 PM
Has Organogenesis Holdings Inc.s (NASDAQ:ORGO) Impressive Stock Performance Got Anything to Do With Its Fundamentals?Has Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
finance.yahoo.com - May 5 at 3:54 PM
Wound Care Biologics Market Demand, Status and Global Briefing 2021 to 2025 | Smith & Nephew, Osiris, Integra, Organogenesis, Amnio Technology – The Shotcaller - The ShotcallerWound Care Biologics Market Demand, Status and Global Briefing 2021 to 2025 | Smith & Nephew, Osiris, Integra, Organogenesis, Amnio Technology – The Shotcaller - The Shotcaller
theshotcaller.net - May 5 at 10:52 AM
Is it Time to Dump Organogenesis Holdings Inc (ORGO) Stock After it Has Risen 0.09% in a Week? - InvestorsObserverIs it Time to Dump Organogenesis Holdings Inc (ORGO) Stock After it Has Risen 0.09% in a Week? - InvestorsObserver
investorsobserver.com - May 4 at 11:03 PM
Organogenesis (NASDAQ:ORGO) Trading Down 7.4%Organogenesis (NASDAQ:ORGO) Trading Down 7.4%
americanbankingnews.com - May 4 at 1:14 PM
COVID-19 Analysis on Advanced Wound Care Market Report for Q1- 2021 compared to 2020|Expected to reach USD 3.15 billion by 2025|Technavio - PRNewswireCOVID-19 Analysis on Advanced Wound Care Market Report for Q1- 2021 compared to 2020|Expected to reach USD 3.15 billion by 2025|Technavio - PRNewswire
prnewswire.com - May 4 at 1:03 PM
Amniotic Products Market Boosting the Growth Worldwide: iMedx, Smith & Nephew, Organogenesis – Clark County Blog - Clark County BlogAmniotic Products Market Boosting the Growth Worldwide: iMedx, Smith & Nephew, Organogenesis – Clark County Blog - Clark County Blog
clarkcountyblog.com - May 4 at 8:03 AM
Organogenesis Holdings Inc. (NASDAQ:ORGO) Sees Large Increase in Short InterestOrganogenesis Holdings Inc. (NASDAQ:ORGO) Sees Large Increase in Short Interest
americanbankingnews.com - May 3 at 4:42 PM
Organogenesis (NASDAQ:ORGO) Shares Gap Up to $22.36Organogenesis (NASDAQ:ORGO) Shares Gap Up to $22.36
americanbankingnews.com - May 3 at 12:06 PM
Amniotic Products Market SWOT Analysis, Business Growth Opportunities by Top Companies : MiMedx,Smith & Nephew,Organogenesis,Integra LifeSciences Corporation – Good News Gum - Good News GumAmniotic Products Market SWOT Analysis, Business Growth Opportunities by Top Companies : MiMedx,Smith & Nephew,Organogenesis,Integra LifeSciences Corporation – Good News Gum - Good News Gum
goodnewsgum.com - May 3 at 10:00 AM
Premarket Mover: Organogenesis Holdings Inc (ORGO) Up 8.14% - InvestorsObserverPremarket Mover: Organogenesis Holdings Inc (ORGO) Up 8.14% - InvestorsObserver
investorsobserver.com - May 3 at 10:00 AM
Skin Substitutes and Wound Care Market Global Analysis 2021-2028: Smith and Nephew, Medtronic (Covidien), Organogenesis, Inc, Scapa Healthcare, and Many More. – Clark County Blog - Clark County BlogSkin Substitutes and Wound Care Market Global Analysis 2021-2028: Smith and Nephew, Medtronic (Covidien), Organogenesis, Inc, Scapa Healthcare, and Many More. – Clark County Blog - Clark County Blog
clarkcountyblog.com - May 1 at 5:51 PM
Organogenesis (NASDAQ:ORGO) Shares Up 4.6%Organogenesis (NASDAQ:ORGO) Shares Up 4.6%
americanbankingnews.com - April 30 at 11:39 AM
Is Organogenesis Holdings Inc (ORGO) Stock a Smart Value Friday? - InvestorsObserverIs Organogenesis Holdings Inc (ORGO) Stock a Smart Value Friday? - InvestorsObserver
investorsobserver.com - April 30 at 10:32 AM
Skin Graft Market 2021 Will Reflect Significant Growth in Future with Size, Share, Growth, and Key Companies Analysis- Organogenesis, Inc., Specmed Medical, Tissue Regenix Group PLC., Avita Medical, Convatec Inc., etc. - Clark County BlogSkin Graft Market 2021 Will Reflect Significant Growth in Future with Size, Share, Growth, and Key Companies Analysis- Organogenesis, Inc., Specmed Medical, Tissue Regenix Group PLC., Avita Medical, Convatec Inc., etc. - Clark County Blog
clarkcountyblog.com - April 29 at 8:01 AM
Global Skin Replacement and Substitute Market 2021 Analysis – Acelity LP Inc., MiMedx Group Inc., Organogenesis Inc. – Valley Bugler Newspaper - Valley Bugler NewspaperGlobal Skin Replacement and Substitute Market 2021 Analysis – Acelity LP Inc., MiMedx Group Inc., Organogenesis Inc. – Valley Bugler Newspaper - Valley Bugler Newspaper
valleybugler.com - April 28 at 3:15 PM
Label Heat Shrinkable Film Market : Growth Factors and Competitive Players till 2026| Allergan, Integra Lifesciences, CR Bard, Zimmer Biomet, Organogenesis, Osiris Therapeutics – Clark County Blog - Clark County BlogLabel Heat Shrinkable Film Market : Growth Factors and Competitive Players till 2026| Allergan, Integra Lifesciences, CR Bard, Zimmer Biomet, Organogenesis, Osiris Therapeutics – Clark County Blog - Clark County Blog
clarkcountyblog.com - April 28 at 10:14 AM
Global Amniotic Product Market 2021 Future Trends – MiMedx, Smith & Nephew, Organogenesis, Integra LifeSciences Corporation, Stryker Corporation, Wright Medical - Valley Bugler NewspaperGlobal Amniotic Product Market 2021 Future Trends – MiMedx, Smith & Nephew, Organogenesis, Integra LifeSciences Corporation, Stryker Corporation, Wright Medical - Valley Bugler Newspaper
valleybugler.com - April 28 at 10:14 AM
Zacks Investment Research Downgrades Organogenesis (NASDAQ:ORGO) to HoldZacks Investment Research Downgrades Organogenesis (NASDAQ:ORGO) to Hold
marketbeat.com - April 17 at 3:20 AM
DateCompanyBrokerageAction
11/27/2020Corcept TherapeuticsHC WainwrightBoost Price Target
8/5/2020Corcept TherapeuticsJefferies Financial GroupDowngrade
2/21/2020Corcept TherapeuticsCantor FitzgeraldReiterated Rating
2/5/2019Corcept TherapeuticsB. RileySet Price Target
8/10/2018Corcept TherapeuticsStifel NicolausReiterated Rating
4/1/2021Rocket PharmaceuticalsSVB LeerinkBoost Price Target
2/25/2021Rocket PharmaceuticalsNeedham & Company LLCInitiated Coverage
1/4/2021Rocket PharmaceuticalsPiper SandlerBoost Price Target
12/15/2020Rocket PharmaceuticalsUBS GroupInitiated Coverage
12/10/2020Rocket PharmaceuticalsEvercore ISIBoost Price Target
12/8/2020Rocket PharmaceuticalsChardan CapitalBoost Price Target
12/8/2020Rocket PharmaceuticalsOppenheimerDowngrade
11/23/2020Rocket PharmaceuticalsJPMorgan Chase & Co.Boost Price Target
10/16/2020Rocket PharmaceuticalsLifesci CapitalReiterated Rating
8/9/2020Rocket PharmaceuticalsCowenReiterated Rating
8/5/2020Rocket PharmaceuticalsCi CapitalReiterated Rating
6/25/2020Rocket PharmaceuticalsBank of AmericaInitiated Coverage
5/6/2020Rocket PharmaceuticalsWilliam BlairReiterated Rating
5/5/2021Deciphera PharmaceuticalsBarclaysLower Price Target
3/30/2021Deciphera PharmaceuticalsCredit Suisse GroupInitiated Coverage
6/12/2020Deciphera PharmaceuticalsGuggenheimReiterated Rating
5/18/2020Deciphera PharmaceuticalsSunTrust BanksBoost Price Target
5/7/2020Deciphera PharmaceuticalsNomura InstinetDowngrade
1/21/2020Deciphera PharmaceuticalsNomura SecuritiesBoost Price Target
1/15/2020Deciphera PharmaceuticalsJMP SecuritiesReiterated Rating
3/3/2021Amicus TherapeuticsRobert W. BairdReiterated Rating
2/12/2021Amicus TherapeuticsCitigroupLower Price Target
12/10/2020Amicus TherapeuticsSmith Barney CitigroupDowngrade
12/10/2020Amicus TherapeuticsCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellDowngrade
11/11/2020Amicus TherapeuticsBerenberg BankInitiated Coverage
6/16/2020Amicus TherapeuticsBTIG ResearchInitiated Coverage
(Data available from 5/8/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.